We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Novel Fluidic Nanodevices Created by Liquid 3D Printing

By LabMedica International staff writers
Posted on 08 May 2019
Researchers have used a novel three-dimensional (3D) printing technique to create an all-liquid fluidic device that is capable performing a wide range of applications - from making battery materials to screening drug candidates.

Systems comprised of immiscible liquids held in non-equilibrium shapes by the interfacial assembly and jamming of nanoparticle-polymer surfactants have significant potential to advance catalysis, chemical separations, energy storage, and conversion. However, directing spatial functionality within them and coupling processes in both phases has remained a challenge.

Investigators at Lawrence Berkeley National Laboratory (CA, USA) exploited nanoclay-polymer surfactant assemblies at an oil-water interface to produce a semi-permeable membrane between the liquids. Flow channels were fabricated using micropatterned two-dimensional (2D) substrates and liquid-in-liquid three-dimensional printing. The anionic walls of the device were functionalized with cationic small molecules, enzymes, and colloidal nanocrystal catalysts. Three-dimensional printing was used to build bridges between channels, connecting them so that a chemical flowing through them encountered catalysts in a specific order, setting off a cascade of chemical reactions to make specific chemical compounds.

The investigators reported in the March 6, 2019, online edition of the journal Nature Communications that multi-step chemical transformations could be conducted within the channels under flow, as could selective mass transport across the liquid-liquid interface for in-line separations. Ultimately, these all-liquid systems were automated using pumps, detectors, and control systems, revealing a latent ability for chemical logic and learning.

"What we demonstrated is remarkable. Our three-dimensional printed device can be programmed to carry out multistep, complex chemical reactions on demand," said senior author Dr. Brett Helms, staff scientist at Lawrence Berkeley National Laboratory. "What is even more amazing is that this versatile platform can be reconfigured to efficiently and precisely combine molecules to form very specific products, such as organic battery materials. The form and functions of these devices are only limited by the imagination of the researcher. Autonomous synthesis is an emerging area of interest in the chemistry and materials communities, and our technique for three-dimensional printing devices for all-liquid flow chemistry could help to play an important role in establishing the field."

Related Links:
Lawrence Berkeley National Laboratory


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
Verification Panels for Assay Development & QC
Seroconversion Panels
New
TORCH Infections Test
TORCH Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.